NIH Clinical Research Studies

Protocol Number: 02-M-0089

Active Accrual, Protocols Recruiting New Patients

Title:
Alpha(2)-Adrenoreceptor (AR) Subtype Polymorphisms and Physiological Responses to Alpha(2)-AR Agonist and Antagonist Drugs
Number:
02-M-0089
Summary:
The purpose of this study is to investigate the role of brain receptors called alpha2-adrenoreceptors in regulating the sympathetic nervous system, which maintains the supply of blood and fuel to the body's organs in times of stress, fear, anger, or exercise.

Alpha(2)-adrenergic receptors (alpha(2)-AR) play a role in a variety of physiological functions. There are three subtypes of alpha(2)-ARs, and their differences are unknown. This study will examine the functional roles of these three subtypes by comparing the behavioral, biochemical, psychophysiological, and autonomic function effects of the alpha(2)-AR drugs clonidine and yohimbine.

Participants in this study will undergo a physical examination, electrocardiogram (ECG), and blood, urine, and saliva tests. Women will have hormone tests to determine the time of their last period and the time of their next ovulation. Participants will undergo neuropsychological testing and other procedures.

Sponsoring Institute:
National Institute of Mental Health (NIMH)
Recruitment Detail
Type: Active Accrual Of New Subjects
Gender: Male & Female
Referral Letter Required: No
Population Exclusion(s): Children

Eligibility Criteria:
INCLUSION CRITERIA

Healthy subjects with a negative first-degree family history of psychiatric disorders as determined by the Family Interview of Genetic Studies are eligible.

Subjects must be willing to participate in a challenge study.

Subjects must be in good physical health.

Subjects must have the absence of any Axis I and Axis II DSM-IV diagnosis.

Subjects will be excluded if they have evidence for an axis I psychiatric disorder or the presence of an axis II personality disorder.

Smokers are ineligible to participate.

Subjects with recent life stressors (3 months) or chronic life stressors (1 year) will be ineligible.

Subjects must be between the ages of 18 and 50.

Subjects must meet criteria for one of 6 genotypically defined subgroups.

Subjects must not have taken antidepressant or other medications likely to alter monoamine neurochemistry or cerebrovascular and cardiovascular function for at least 6 months prior to the challenge studies.

EXCLUSION CRITERIA

Subjects will be excluded if they have medical or neurological illnesses likely to affect physiology or anatomy, i.e. hypertension, cardiovascular disorders.

Subjects must not have a history of drug (including BZDs) or alcohol abuse within 1 year or a lifetime history of alcohol or drug dependence.

Subjects with current or previous regular use (greater than 4 weeks) of BZDs and excessive use of alcohol (greater than 8 ounces/week for men and greater than 6 ounces/week for women) in the past or present are ineligible to participate.

Women who are currently pregnant or breastfeeding are not eligible.

Subjects who cannot hear a 40 dB(HL) pure tone in the 1000- to 4000 Hz span (Welsh Allen audioscope) will be excluded from studies.

Special Instructions: Currently Not Provided
Keywords:
Alpha2-Adrenoreceptors
Polymorphisms
Challenge Study
Yohimbine
Clonidine
Subtypes
Recruitment Keywords:
Normal Control
HV
Healthy Volunteer
Challenge Study
Conditions:
Healthy
Investigational Drug(s):
Yohimbine
Investigational Device(s):
None

Contacts:
Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

Electronic Mail:prpl@mail.cc.nih.gov

Citations:
Eisenhofer G, et al Sympathetic nervous function [PMID:1572033]

O'Dowd BF, et al Structure of the adrenergic a[PMID:2648960]

Venter JC, et al Molecular biology of adrenerg[PMID:2650684]

Active Accrual, Protocols Recruiting New Patients

If you have:


Command Menu Bar

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home


Clinical Center LogoWarren Grant Magnuson Clinical Center (CC)
National Institutes of Health (NIH)
Bethesda, Maryland 20892. Last update: 10/21/2004

Search The Studies Help Questions